Fig. 4From: Cyclophosphamide induced early remission and was superior to rituximab in idiopathic membranous nephropathy patients with high anti-PLA2R antibody levelsComparison of immunologic response rate between rituximab and cyclophosphamide groups in IMN patientsBack to article page